Search Results for "Crux Vcf"
Original Source: FDA Clears First Ever Bi-directionally Retrievable Vena Cava Filter from Crux Biomedical
Crux Biomedical announced it has received U.S. Food and Drug Administration (FDA) clearance for its novel inferior vena cava filter (VCF) with bi-directional retrieval. VCF are designed to trap blood clots that can lead to potentially fatal pulmonary embolisms among patients at risk. The Crux VCF (see image) is the first and only VCF designed to facilitate bi-directional retrieval through either the femoral or jugular veins, a key consideration when ac...
Matching Channels
None
Matching News
Volcano to acquire Crux Biomedical
Volcano, a developer and manufacturer of precision guided therapy tools for treatment of coronary and peripheral vascular disease, has signed an agreement to acquire Crux Biomedical, a privately-held...
Volcano to take over Crux Biomedical
Volcano, a manufacturer of precision guided therapy tools, has entered into an agreement to buy US-based Crux Biomedical for $36m in cash.
Crux gains FDA OK for device to treat pulmonary embolisms
The FDA has granted Crux Biomedical approval for the Inferior Vena Cava Filter, which is used to obstruct blood clots that ca -More-
San Diego’s Volcano Paying $36M+ for Menlo Park’s Crux Biomed
San Diego vascular device maker Volcano Corp. (NASDAQ: VOLC) today disclosed an agreement to pay at least $36 million for Menlo Park, CA-based Crux Biomedical. The Crux deal comes just a few weeks aft...
[Volcano Corp.] buys [Crux Biomedical]
The same month it netted $445.3mm through a notes offering, [Volcano Corp.] has agreed to buy closely held minimally invasive cardiovascular device company [Crux Biomedical Inc.] for $36mm in cash, up...
Volcano boosts cardiovascular footprint with Crux Biomedical buy
Volcano hopes to expand its cardiovascular device portfolio by acquiring Crux Biomedical, maker of a vena cava filter designe -More- Free On-Demand Webinar: Pilgrim Training Management Produ...
FDA Clears First Ever Bi-directionally Retrievable Vena Cava Filter from Crux Biomedical
Crux Biomedical announced it has received U.S. Food and Drug Administration (FDA) clearance for its novel inferior vena cava filter (VCF) with bi-directional retrieval. VCF are de...
You’ll Soon Be Able to Buy ‘Plan B’ as Easily as You Buy Shampoo
Hindrances to women’s sexual health abound from state to state. Lengthy and expensive arguments over abortion and women’s contraception seem par for the course in politics today, with the crux of...
Matching PubMed Articles
The RETRIEVE Trial: Safety and Effectiveness of the Retrievable Crux Vena Cava Filter.
To evaluate the safety and effectiveness of the Crux vena cava filter in patients at risk for pulmonary embolism (PE).
Faster SEQUEST Searching for Peptide Identification from Tandem Mass Spectra.
Computational analysis of mass spectra remains the bottleneck in many proteomics experiments. SEQUEST was one of the earliest software packages to identify peptides from mass spectra by searching a da...
The crux of the confusion about screening mammograms.
Microbial translocation and AIDS-associated lymphomas: crux of the problem.
We present the case of a 76-year-old patient in whom coronary angiography, performed due to non-ST-segment elevation myocardial infarction, revealed an isolated single coronary (SCA) artery with dual...
